Tenpoint Therapeutics, Ltd. announced that YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is now available in the U.S. for the treatment of presbyopia...
Tenpoint Therapeutics, Ltd. announced that the U.S. Food and Drug Administration (FDA) approved YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, previously known as...